MiRNA-26b overexpression in ulcerative colitis-associated carcinogenesis

Inflammatory Bowel Diseases

Volumn 21, Issue 9, 2015, Pages 2039-2051

  Benderska, Natalya ^a   Dittrich, Anna Lena ^a   Knaup, Sabine ^a   Rau, Tilman T ^a   Neufert, Clemens ^a   Wach, Sven ^b   Fahlbusch, Fabian B ^a   Rauh, Manfred ^a   Wirtz, Ralph M ^c   Agaimy, Abbas ^a   Srinivasan, Swetha ^d   Mahadevan, Vijayalakshmi ^d   Rümmele, Petra ^e   Rapti, Emmanouela ^f   Gazouli, Maria ^f   Hartmann, Arndt ^a   Schneider Stock, Regine ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Departments of Urology   (United States)

^c STRATIFYER Molecular Pathology GmbH   (Germany)

^d SASTRA UNIVERSITY   (India)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

colorectal carcinoma; inflammation; microRNA; MIR 26b; ulcerative colitis

Indexed keywords

ARGONAUTE 2 PROTEIN; BRCA1 PROTEIN; CREBBP PROTEIN; DEATH ASSOCIATED PROTEIN KINASE; DIP1 PROTEIN; KI 67 ANTIGEN; MESSENGER RNA; MICRORNA; MICRORNA 26B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN MDM2; UNCLASSIFIED DRUG; ARGONAUTE PROTEIN; CCNDBP1 PROTEIN, HUMAN; CREBBP PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; EIF2C2 PROTEIN, HUMAN; LUCIFERASE; MDM2 PROTEIN, HUMAN; MIRN26A MICRORNA, HUMAN; RNA; TRANSCRIPTION FACTOR; TUMOR MARKER;

3' UNTRANSLATED REGION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; COHORT ANALYSIS; COLON BIOPSY; COLON CANCER; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EPITHELIUM TUMOR; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HCT116 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; IN VIVO STUDY; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TISSUE MICROARRAY; ULCERATIVE COLITIS; UPREGULATION; WESTERN BLOTTING; BLOOD; CELIAC DISEASE; CHILD; COLON; COLORECTAL TUMOR; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; ARGONAUTE PROTEINS; BIOMARKERS, TUMOR; BRCA1 PROTEIN; CARCINOGENESIS; CELIAC DISEASE; CHILD; COLITIS, ULCERATIVE; COLON; COLORECTAL NEOPLASMS; CREB-BINDING PROTEIN; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS C-MDM2; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION FACTORS;

EID: 84940938118     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000453     Document Type: Article

References (60)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374-1403.
2. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91: 854-862.
3. Habermann J, Lenander C, Roblick UJ, et al. Ulcerative colitis and colorectal carcinoma: DNA-profile, laminin-5 gamma2 chain and cyclin A expression as early markers for risk assessment. Scand J Gastroenterol. 2001;36:751-758.
4. Terzic J, Grivennikov S, Karin E, et al. Inflammation and colon cancer. Gastroenterology. 2010;138:2101-2114.e2105.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
6. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522-531.
7. O'Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol. 2012;30:295-312.
8. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259-269.
9. Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11: 228-234.
10. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838.
11. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development. 2005;132:4653-4662.
12. Cowland JB, Hother C, Gronbaek K. MicroRNAs and cancer. APMIS. 2007;115:1090-1106.
13. Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006;103:12481-12486.
14. Chen R, Alvero AB, Silasi DA, et al. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene. 2008;27: 4712-4723.
15. Lu Z, Li Y, Takwi A, et al. miR-301a as an NF-kappaB activator in pancreatic cancer cells. EMBO J. 2011;30:57-67.
16. Ludwig K, Fassan M, Mescoli C, et al. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. Virchows Arch. 2013;462:57-63.
17. Olaru AV, Yamanaka S, Vazquez C, et al. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:471-480.
18. Olaru AV, Cheng Y, Agarwal R, et al. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers. Inflamm Bowel Dis. 2012;18:641-648.
19. Wu F, Zikusoka M, Trindade A, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology. 2008;135: 1624-1635.e1624.
20. Gao J, Liu QG The role of miR-26 in tumors and normal tissues (Review). Oncol Lett. 2011;2:1019-1023.
21. Palumbo T, Faucz FR, Azevedo M, et al. Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somato-mammotrophic tumor growth through activation of the PTEN-AKT pathway. Oncogene. 2013;32:1651-1659.
22. Wu N, Zhao X, Liu M, et al. Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PLoS One. 2011;6: e16264.
23. Gottardo F, Liu CG, Ferracin M, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007;25:387-392.
24. Liu XX, Li XJ, Zhang B, et al. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett. 2011;585:1363-1367.
25. Ji Y, He Y, Liu L, et al. MiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cells. FEBS Lett 2010;584:961-967.
26. Gramantieri L, Fornari F, Callegari E, et al. MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med. 2008;12:2189-2204.
27. Zhang C, Tong J, Huang G. Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells. PLoS One. 2013;8:e69963.
28. Zhang Z, Kim K, Li X, et al. MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression. Mol Cancer Ther. 2014;13:1942-1951.
29. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429.
30. Treem WR. Emerging concepts in celiac disease. Curr Opin Pediatr. 2004;16:552-559.
31. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185-1194.
32. Neufert C, Becker C, Neurath MF. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc. 2007;2:1998-2004.
33. Castro F, Dirks WG, Fahnrich S, et al. High-throughput SNP-based authentication of human cell lines. Int J Cancer. 2013;132:308-314.
34. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue [in German]. Pathologe. 1987; 8:138-140.
35. Erhard F, Dolken L, Jaskiewicz L, et al. PARma: identification of micro-RNA target sites in AGO-PAR-CLIP data. Genome Biol. 2013;14:R79.
36. Beinder L, Faehrmann N, Wachtveitl R, et al. Detection of expres-sional changes induced by intrauterine growth restriction in the developing rat mammary gland via exploratory pathways analysis. PLoS One. 2014;9:e100504.
37. Hulsen T, de Vlieg J, Alkema W. BioVenn-a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics. 2008;9:488.
38. Vlassov AV, Magdaleno S, Setterquist R, et al. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012;1820:940-948.
39. Yang HB, Liang W, Liu XX, et al. Detection of dynamic expression of microRNAs in vivo using a dual-fluorescence reporter system/miRNA Tracer in zebrafish [in Chinese]. Yi Chuan. 2012;34:1181-1192.
40. Chakilam S, Gandesiri M, Rau TT, et al. Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. Am J Pathol. 2013; 182:1005-1020.
41. Zhang L, Nephew KP, Gallagher PJ. Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes. J Biol Chem. 2007; 282:11795-11804.
42. Craig AL, Chrystal JA, Fraser JA, et al. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members. Mol Cell Biol. 2007;27:3542-3555.
43. Bajbouj K, Poehlmann A, Kuester D, et al. Identification of phosphorylated p38 as a novel DAPK-interacting partner during TNFalpha-induced apopto-sis in colorectal tumor cells. Am J Pathol. 2009;175:557-570.
44. Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcino-genesis. 2010;31:37-49.
45. Leeper NJ, Raiesdana A, Kojima Y, et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol. 2011; 226:1035-1043.
46. Zhao N, Wang R, Zhou L, et al. MicroRNA-26b suppresses the NF-kappaB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. Mol Cancer. 2014;13:35.
47. Benderska N, Schneider-Stock R. Transcription control of DAPK. Apo-ptosis. 2014;19:298-305.
48. Jin Y, Blue EK, Dixon S, et al. A death-associated protein kinase (DAPK)-interacting protein, DIP-1, is an E3 ubiquitin ligase that promotes tumor necrosis factor-induced apoptosis and regulates the cellular levels of DAPK. J Biol Chem. 2002;277:46980-46986.
49. Henshall DC, Araki T, Schindler CK, et al. Expression of death-associated protein kinase and recruitment to the tumor necrosis factor signaling pathway following brief seizures. J Neurochem. 2003;86: 1260-1270.
50. Capoccia BJ, Jin RU, Kong YY, et al. The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. J Clin Invest. 2013; 123:1475-1491.
51. Itoh M, Kim CH, Palardy G, et al. Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell. 2003;4:67-82.
52. Chen W, Casey Corliss D. Three modules of zebrafish Mind bomb work cooperatively to promote Delta ubiquitination and endocytosis. Dev Biol. 2004;267:361-373.
53. Barsi JC, Rajendra R, Wu JI, et al. Mind bomb1 is a ubiquitin ligase essential for mouse embryonic development and Notch signaling. Mech Dev. 2005;122:1106-1117.
54. Zhang L, Gallagher PJ. Mind bomb 1 regulation of cFLIP interactions. Am J Physiol Cell Physiol. 2009;297:C1275-C1283.
55. Coskun M, Bjerrum JT, Seidelin JB, et al. miR-20b, miR-98, miR-125b-1∗, and let-7e∗ as new potential diagnostic biomarkers in ulcerative colitis. World J Gastroenterol. 2013;19:4289-4299.
56. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11: 441-450.
57. Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008;9:219-230.
58. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006.
59. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513-10518.
60. Bai J, Li Y, Shao T, et al. Integrating analysis reveals microRNA-mediated pathway crosstalk among Crohn's disease, ulcerative colitis and colorectal cancer. Mol BioSyst. 2014;10:2317-2328.